Mint Tower Capital Management B.V. »

Revance Therapeutics shares owned by Mint Tower Capital Management B.V.

Quarter-by-quarter ownership of Revance Therapeutics shares owned by Mint Tower Capital Management B.V. from 13F filings

Historical chart of Mint Tower Capital Management B.V. investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Mint Tower Capital Management B.V. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Mint Tower Capital Management B.V.

Quarter filed Position value Share count Share price at filing
2024-12-31 $570k 187k 3.04
2024-09-30 $311k 60k 5.18

More positions owned by Mint Tower Capital Management B.V.

Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Strategy Note 0.625% 9/1 (Principal)
Strategy Note 0.625% 3/1 (Principal)
Stride Note 1.125% 9/0 (Principal)
Echostar Corp Note 3.875%11/3 (Principal)
Uber Technologies (UBER)
Axon Enterprise Note 0.500%12/1 (Principal)
SPDR KBW Regional Banking Call Option (KRE)
Snowflake Note 10/0 (Principal)
Launch Two Acquisition Corp . Ord Shs Cl A (LPBB)
Rbc Cad Put Option (RY)
Pdd Holdings Note 12/0 (Principal)
Ishares Ethereum Tr SHS (ETHA)
Hcm Iii Acquisition Corp Unit 07/23/2030

View all positions for Mint Tower Capital Management B.V.